Vistra Corp. (VST) Stock News

Vistra Corp. (VST) has been trending on Zacks.com with shares up 6.3% over the past month, outperforming the S&P 500. However, the company received a Zacks Rank #4 (Sell) rating despite strong earnings growth projections of +71.9% for the current fiscal year and +16.6% for next year. The stock is valued at par with peers (Grade C) but may underperform the broader market in the near term.

Vistra Corp. (VST) has attracted investor attention recently. While the company shows strong earnings growth projections (+71.9% for current fiscal year) and revenue growth (+27.4% for current fiscal year), it received a Zacks Rank #4 (Sell) rating. The stock has underperformed the S&P 500 over the past month (-3% vs +0.8%), and trades at par valuation with peers. Recent earnings surprised positively on EPS but missed significantly on revenue expectations.

Vistra Corp. (VST) declined 1.74% to $137.97, underperforming the S&P 500's 0.76% loss. Despite the recent dip, the stock has gained 0.99% over the past month. Analysts project strong earnings growth with EPS expected to increase 65.14% and revenue up 56.19% year-over-year. The company holds a Zacks Rank #3 (Hold) with a Forward P/E of 15.53, trading at a discount to its industry average.

Kaplan Fox has filed a securities class action lawsuit against Microvast Holdings (MVST) on behalf of investors who suffered losses between April 1, 2025 and March 16, 2026. The lawsuit alleges that Microvast made false statements about its manufacturing expansion (Huzhou Phase 3.2) and profit margins, which were contradicted by a Grizzly Research report and subsequent company disclosures showing gross margins collapsed to 1% and revenue declined 15% year-over-year.

A securities class action lawsuit has been filed against Microvast Holdings, Inc. (NASDAQ: MVST) for allegedly making materially false and misleading statements regarding margin targets, inventory management issues, and delays in the Huzhou Phase 3.2 expansion. Investors who purchased MVST securities between April 1, 2025 and March 16, 2026 may be eligible for compensation. The lead plaintiff deadline is September 21, 2026.

A class action securities fraud lawsuit has been filed against Microvast Holdings, Inc. for allegedly making materially false statements about its business operations between April 1, 2025 and March 16, 2026. The company allegedly overstated production facility activity, margin targets, and the timeline for completing its Huzhou Phase 3.2 expansion. The stock declined significantly following multiple negative announcements, including a CFO departure and disappointing financial results showing gross margin collapse to 1%. Shareholders have until September 21, 2026 to file a lead plaintiff motion.

Rosen Law Firm is notifying investors in Microvast Holdings (MVST) and Avis Budget Group (CAR) about ongoing securities class action lawsuits. MVST investors who purchased between April 1, 2025 and March 16, 2026 may be entitled to compensation due to alleged false statements regarding margin targets and facility expansion delays. The lead plaintiff deadline for MVST is September 21, 2026. Similar class action proceedings are underway for CAR investors.

Rosen Law Firm announces class action securities lawsuits against Microvast Holdings, Inc. (MVST) and GPGI, Inc. (formerly CompoSecure, Inc.). The MVST lawsuit alleges defendants made false statements regarding profitability targets, manufacturing expansion capabilities, and vehicle launch timelines. Investors who suffered losses exceeding $100,000 during the relevant periods are encouraged to seek legal representation before the September 21, 2026 deadline for MVST and September 14, 2026 for GPGI.

Holzer & Holzer, LLC announced lead plaintiff deadlines for shareholder class action lawsuits against three companies. Photronics (PLAB) faces allegations of false statements regarding its product pipeline and demand stability (deadline: September 4, 2026). Planet Fitness (PLNT) is accused of misrepresenting its Black Card price increase rollout and membership growth (deadline: September 14, 2026). Microvast (MVST) allegedly made false statements about gross margin targets and inventory management (deadline: September 21, 2026). Investors who suffered losses during the alleged fraud periods are encouraged to seek lead plaintiff status.

Rosen Law Firm announces September 21, 2026 deadline for investors to join a securities class action lawsuit against Microvast Holdings, Inc. (MVST). The lawsuit alleges the company made false statements regarding profitability targets, manufacturing capabilities at its Huzhou facility, and inventory management issues, causing investor losses.

Rosen Law Firm reminds Microvast Holdings (MVST) investors of the September 21, 2026 lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that Microvast made materially false and misleading statements regarding margin targets, inventory management issues, delays in customer vehicle rollouts, and the Huzhou Phase 3.2 expansion completion timeline.

Rosen Law Firm is alerting investors in Microvast Holdings (MVST) about a securities class action lawsuit with a September 21, 2026 lead plaintiff deadline. The lawsuit alleges that Microvast made materially false and misleading statements regarding margin targets, inventory management, and delays in the Huzhou Phase 3.2 expansion, causing investor losses.

Rosen Law Firm is encouraging investors who purchased securities of Microvast Holdings (MVST) between April 1, 2025 and March 16, 2026 to join a class action lawsuit. The lawsuit alleges that Microvast made materially false and misleading statements regarding margin targets, inventory management, and delays in the Huzhou Phase 3.2 expansion. The lead plaintiff deadline is September 21, 2026. Similar class action notices are being issued for PROCEPT BioRobotics and TransMedics Group.

Rosen Law Firm is notifying investors about multiple securities class action lawsuits. The primary case involves Microvast Holdings, with allegations that the company made false statements about margin targets and the Huzhou Phase 3.2 expansion completion timeline. The lead plaintiff deadline is September 21, 2026. Similar notices are being issued for Hub Group and Peabody Energy.

A class action lawsuit has been filed against Microvast Holdings, Inc. (NASDAQ: MVST) for alleged securities fraud. The complaint alleges that company executives made materially false and misleading statements regarding business operations, margin targets, and the Huzhou Phase 3.2 expansion timeline. The lawsuit covers investors who purchased Microvast securities between April 1, 2025 and March 16, 2026. The stock experienced significant declines following revelations of inventory issues, delayed production capacity expansion, and a sharp drop in gross margins from 36% to 1%.

Law Offices of Howard G. Smith announced class action lawsuits against three publicly-traded companies for securities fraud. Insulet Corporation faces allegations of defective manufacturing controls, Microvast Holdings is accused of overstating margin targets and expansion timelines, and Hub Group is charged with material misstatements in financial reporting. Investors have until late August and September 2026 to file lead plaintiff motions.

Rosen Law Firm is urging investors who purchased Microvast Holdings securities between April 1, 2025 and March 16, 2026 to join a class action lawsuit. The lawsuit alleges that Microvast made materially false and misleading statements regarding margin targets, inventory management issues, and delays in the Huzhou Phase 3.2 expansion completion. The lead plaintiff deadline is September 21, 2026.

Rosen Law Firm is reminding investors who purchased Microvast Holdings securities between April 1, 2025 and March 16, 2026 of an important September 21, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Microvast made materially false and misleading statements regarding margin targets, inventory management issues, and delays in the Huzhou Phase 3.2 expansion completion.

Rosen Law Firm has filed class action lawsuits against Microvast Holdings, Inc. and other companies on behalf of investors who purchased securities during specified periods. The lawsuit alleges that Microvast made materially false and misleading statements regarding margin targets, inventory management, and the completion of facility expansions. Investors who purchased securities during the class period may be eligible for compensation.

Rosen Law Firm has filed a class action lawsuit on behalf of Microvast Holdings investors who purchased securities between April 1, 2025 and March 16, 2026. The lawsuit alleges that defendants made materially false and misleading statements regarding margin targets, inventory management issues, delays in commercial vehicle rollouts, and the completion timeline of the Huzhou Phase 3.2 expansion. Investors must move the court by September 21, 2026 to serve as lead plaintiff.

Atlas Healthcare Fund, managed by VST Capital, showcased its track record of early conviction investments in healthcare, with notable positions in Eli Lilly (entered at $350, now trading above $1,200), Alnylam Pharmaceuticals, TransMedics Group, and Inari Medical. The fund has delivered cumulative net returns of +1,720.9% since inception in January 2020, averaging over 57% annually, by identifying clinically differentiated technologies before mainstream market recognition.